GD-GABAPENTIN
GENMED A DIVISION OF PFIZER CANADA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GD-GABAPENTIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GD-GABAPENTIN 300MG has been permanently discontinued (last updated January 14, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GD-GABAPENTIN not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
PMS-GABAPENTIN
PHARMASCIENCE INC
GABAPENTIN
SIVEM PHARMACEUTICALS ULC
RIVA-GABAPENTIN
LABORATOIRE RIVA INC.
AURO-GABAPENTIN
AURO PHARMA INC
PRO-GABAPENTIN
PRO DOC LIMITEE
AURO-GABAPENTIN TABLETS
AURO PHARMA INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02285827
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada